Company Dynamics Update
On March 25, 2025, Huainan Jiankun Pharmaceutical Co., Ltd. (Jiankun Pharmaceutical) announced the successful acceptance of the environmental impact report for its production project encompassing 70 t/a VD3 oil, 3,500 t/a VD3 powder, and 5 t/a VD3 crystals. The project was officially accepted by the Huainan Municipal Ecology and Environment Bureau.
Project Overview and Investment Details
Located at the northeast side of the intersection of Luojiu Road and Ji’an Road in the Chemical Concentration Area of the Huainan Economic and Technological Development Zone, the project is a reconstruction, renovation, and expansion initiative. Key project highlights include:
- Total Investment: USD 10.73 million (RMB 77.00 million)
- Environmental Protection Investment: USD 0.29 million (RMB 2.05 million)
The project will fully utilize Jiankun Pharmaceutical’s existing factory buildings, and will involve the purchase and installation of advanced production equipment such as reactors, condensers, spray dryers, and various specialized pumps. The new production lines will cover:
- 70 tons per annum (t/a) of VD3 oil
- 3,500 t/a of VD3 powder
- 5 t/a of VD3 crystals
Environmental Compliance and Sustainability
The project prioritizes environmental sustainability by integrating modern environmental protection facilities aimed at reducing emissions and ensuring compliance with China’s stringent environmental regulations. This highlights Jiankun Pharmaceutical’s commitment to responsible manufacturing practices within the pharmaceutical sector.
Company Background
Jiankun Pharmaceutical specializes in the production of active pharmaceutical ingredients (APIs), particularly focusing on vitamin D3-related products. Strategically located in Huainan’s Chemical Concentration Area, the company leverages advanced manufacturing technologies and strict quality control systems to meet domestic and international standards.
Industry Outlook
With the expanding global demand for vitamin D3 in pharmaceuticals, supplements, and fortified foods, Jiankun Pharmaceutical’s project positions the company to play a larger role in international markets. Enhanced production capacity will contribute to stabilizing supply chains and meeting the surging demand for high-quality VD3 products.
Accelerate Your Business with China Informatics
Partner with China Informatics for:
- Real-time insights on pharmaceutical project approvals and regulatory trends.
- Strategic intelligence on vitamin D3 market developments and expansions.
- Comprehensive analysis of company dynamics and environmental initiatives in China.
Equip your business with expert intelligence tailored for global market leaders. Connect with China Informatics today.
